10x Genomics, Inc. Industry Peers
Companies in the Life Sciences Tools & Services industry
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Life Sciences Tools & Services
20 companies in this industry (including TXG)
Sector: Health Care
Other Companies in Life Sciences Tools & Services
| Company | Revenue | Profit Margin | ROE |
|---|---|---|---|
| Thermo Fisher Scientific(TMO) | $43.74B | 15.0% | 12.9% |
| Danaher Corporation(DHR) | $24.27B | 14.4% | 6.9% |
| IQVIA(IQV) | $15.90B | 8.1% | 20.8% |
| Agilent Technologies(A) | $6.95B | 18.8% | - |
| Avantor(AVTR) | $6.58B | -1.3% | -1.5% |
| Illumina, Inc.(ILMN) | $4.29B | 16.4% | 29.5% |
| Charles River Laboratories(CRL) | $4.02B | -2.0% | -2.4% |
| Mettler Toledo(MTD) | $3.94B | 21.2% | - |
| Waters Corporation(WAT) | $2.96B | 21.6% | 34.9% |
| Bio-Rad Laboratories(BIO) | $2.56B | - | 23.0% |
| Medpace(MEDP) | $2.36B | 18.4% | 147.5% |
| Bio-Techne(TECH) | $1.22B | 6.0% | - |
| Azenta, Inc.(AZTA) | $593.82M | -9.4% | - |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.(PACB) | $78.63M | - | - |
| Intellia Therapeutics, Inc.(NTLA) | $57.88M | - | - |
| EyePoint, Inc.(EYPT) | $43.27M | - | - |
| Celldex Therapeutics, Inc.(CLDX) | $7.02M | - | - |
| ICON PLC(ICLR) | - | - | - |
| Anbio Biotechnology(NNNN) | - | - | - |
Data source: SEC EDGAR filings. Financial data may be from the most recent fiscal year.